Has Mark Cumings, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,120 in general payments to Mark Cumings, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Cumings, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Cumings, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Cumings, MD

Gastroenterology · Olympia, WANPI 1629132584

Payments from drug & device makers

$1,120in general payments, 2019–2025

Across 23 payments — averaging $48.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Fujifilm Healthcare Americas Corporation$790
Olympus America Inc.$169
Madrigal Pharmaceuticals$60
AbbVie$42
Gilead$25
Fresenius Kabi USA, LLC$19
plus $16 from 1 others

What the payments were for

Food & beverage$33029%
Gifts$52447%
Other$26624%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Fujifilm Healthcare Americas Corporation	9	$790
Olympus America Inc.	8	$169
Madrigal Pharmaceuticals	1	$60
AbbVie	1	$42
Gilead	2	$25
Fresenius Kabi USA, LLC	1	$19
Pfizer	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ESD - Core Endoscopy$280
FUJIFILM$202

How this compares

$1,120 in reported general payments places this provider in the 55th percentile of 447 gastroenterology providers in Washington.

See all gastroenterology providers in Washington →

Medicare billing

Part B allowed, 2024

$83,713

Medicare patients

364

Services billed

590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XifaxanRifaximin	13	$44,908
Spironolactone	20	$788
Pantoprazole Sodium	59	$698
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	35	$682
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl	37	$646
Omeprazole	32	$593
Propranolol Hcl	14	$303
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	13	$298
Furosemide	16	$110

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Olympia

Kris KowdleySeattle$5.9M
Michael ChioreanIssaquah$3.9M
Scott LeeSeattle$3.7M
Timothy ZismanSeattle$3.3M
William HoldermanTacoma$3.1M
James LordSeattle$1.9M
Charles LandisSeattle$1.7M
Robert WohlmanBellevue$1.5M
Asma SiddiqueSeattle$1.3M
Harold PreiksaitisSpokane$1M

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →